Literature DB >> 19276082

Erythrocyte hemolysis and hemoglobin oxidation promote ferric chloride-induced vascular injury.

Kevin J Woollard1, Sharelle Sturgeon, Jaye P F Chin-Dusting, Hatem H Salem, Shaun P Jackson.   

Abstract

The release of redox-active iron and heme into the blood-stream is toxic to the vasculature, contributing to the development of vascular diseases. How iron induces endothelial injury remains ill defined. To investigate this, we developed a novel ex vivo perfusion chamber that enables direct analysis of the effects of FeCl(3) on the vasculature. We demonstrate that FeCl(3) treatment of isolated mouse aorta, perfused with whole blood, was associated with endothelial denudation, collagen exposure, and occlusive thrombus formation. Strikingly exposing vessels to FeCl(3) alone, in the absence of perfused blood, was associated with only minor vascular injury. Whole blood fractionation studies revealed that FeCl(3)-induced vascular injury was red blood cell (erythrocyte)-dependent, requiring erythrocyte hemolysis and hemoglobin oxidation for endothelial denudation. Overall these studies define a unique mechanism of Fe(3+)-induced vascular injury that has implications for the understanding of FeCl(3)-dependent models of thrombosis and vascular dysfunction associated with severe intravascular hemolysis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19276082      PMCID: PMC2676043          DOI: 10.1074/jbc.M809095200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  47 in total

Review 1.  Forging a field: the golden age of iron biology.

Authors:  Nancy C Andrews
Journal:  Blood       Date:  2008-07-15       Impact factor: 22.113

2.  Diaspirin cross-linked hemoglobin (DCLHb) in the treatment of severe traumatic hemorrhagic shock: a randomized controlled efficacy trial.

Authors:  E P Sloan; M Koenigsberg; D Gens; M Cipolle; J Runge; M N Mallory; G Rodman
Journal:  JAMA       Date:  1999-11-17       Impact factor: 56.272

3.  Heme degradation during autoxidation of oxyhemoglobin.

Authors:  E Nagababu; J M Rifkind
Journal:  Biochem Biophys Res Commun       Date:  2000-07-14       Impact factor: 3.575

4.  A phase I study of oxidized raffinose cross-linked human hemoglobin.

Authors:  F J Carmichael; A C Ali; J A Campbell; S F Langlois; G P Biro; A R Willan; C H Pierce; A G Greenburg
Journal:  Crit Care Med       Date:  2000-07       Impact factor: 7.598

5.  Heme is a potent inducer of inflammation in mice and is counteracted by heme oxygenase.

Authors:  F A Wagener; A Eggert; O C Boerman; W J Oyen; A Verhofstad; N G Abraham; G Adema; Y van Kooyk; T de Witte; C G Figdor
Journal:  Blood       Date:  2001-09-15       Impact factor: 22.113

6.  Neutrophil activation by heme: implications for inflammatory processes.

Authors:  Aurélio V Graça-Souza; Maria Augusta B Arruda; Marta S de Freitas; Christina Barja-Fidalgo; Pedro L Oliveira
Journal:  Blood       Date:  2002-06-01       Impact factor: 22.113

7.  Reaction of hydrogen peroxide with ferrylhemoglobin: superoxide production and heme degradation.

Authors:  E Nagababu; J M Rifkind
Journal:  Biochemistry       Date:  2000-10-10       Impact factor: 3.162

8.  Pathophysiological levels of soluble P-selectin mediate adhesion of leukocytes to the endothelium through Mac-1 activation.

Authors:  Kevin J Woollard; Andreas Suhartoyo; Emma E Harris; Steffen U Eisenhardt; Shaun P Jackson; Karlheinz Peter; Anthony M Dart; Michael J Hickey; Jaye P F Chin-Dusting
Journal:  Circ Res       Date:  2008-09-25       Impact factor: 17.367

9.  Vascular dysfunction in a murine model of severe hemolysis.

Authors:  Anne C Frei; YiHe Guo; Deron W Jones; Kirkwood A Pritchard; Karen A Fagan; Neil Hogg; Nancy J Wandersee
Journal:  Blood       Date:  2008-05-13       Impact factor: 22.113

10.  Randomized trial of diaspirin cross-linked hemoglobin solution as an alternative to blood transfusion after cardiac surgery. The DCLHb Cardiac Surgery Trial Collaborative Group.

Authors:  M L Lamy; E K Daily; J F Brichant; R P Larbuisson; R H Demeyere; E A Vandermeersch; J J Lehot; M R Parsloe; J C Berridge; C J Sinclair; J F Baron; R J Przybelski
Journal:  Anesthesiology       Date:  2000-03       Impact factor: 7.892

View more
  41 in total

1.  In vivo imaging analysis of the interaction between unusually large von Willebrand factor multimers and platelets on the surface of vascular wall.

Authors:  Miroslaw Rybaltowski; Yuko Suzuki; Hideo Mogami; Iwona Chlebinska; Tomasz Brzoska; Aki Tanaka; Fumiaki Banno; Toshiyuki Miyata; Tetsumei Urano
Journal:  Pflugers Arch       Date:  2011-04-15       Impact factor: 3.657

2.  Occlusive thrombi arise in mammals but not birds in response to arterial injury: evolutionary insight into human cardiovascular disease.

Authors:  Alec A Schmaier; Timothy J Stalker; Jeffrey J Runge; Dooyoung Lee; Chandrasekaran Nagaswami; Patricia Mericko; Mei Chen; Simon Cliché; Claude Gariépy; Lawrence F Brass; Daniel A Hammer; John W Weisel; Karen Rosenthal; Mark L Kahn
Journal:  Blood       Date:  2011-08-03       Impact factor: 22.113

3.  Antibiotic resistance and tolerance to simulated gastrointestinal conditions of eight hemolytic Bacillus pumilus isolated from pulque, a traditional Mexican beverage.

Authors:  Raquel González-Vázquez; Lino Mayorga-Reyes; Armando Monroy-López; Luis A Reyes-Nava; Yadira Rivera-Espinoza; Alejandro Azaola-Espinosa
Journal:  Food Sci Biotechnol       Date:  2017-04-30       Impact factor: 2.391

4.  Overexpression of the cell cycle inhibitor p16INK4a promotes a prothrombotic phenotype following vascular injury in mice.

Authors:  Jessica C Cardenas; A Phillip Owens; Janakiraman Krishnamurthy; Norman E Sharpless; Herbert C Whinna; Frank C Church
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-01-13       Impact factor: 8.311

5.  Hemojuvelin modulates iron stress during acute kidney injury: improved by furin inhibitor.

Authors:  Guang-Huar Young; Tao-Min Huang; Che-Hsiung Wu; Chun-Fu Lai; Chun-Cheng Hou; Kang-Yung Peng; Chan-Jung Liang; Shuei-Liong Lin; Shih-Chung Chang; Pi-Ru Tsai; Kwan-Dun Wu; Vin-Cent Wu; Wen-Je Ko
Journal:  Antioxid Redox Signal       Date:  2013-09-17       Impact factor: 8.401

6.  Thalidomide remodels developing heart in chick embryo: discovery of a thalidomide mediated hematoma in heart muscle.

Authors:  Pavitra Kumar; Harish A Kumar; Lakshmikirupa Sundaresan; Anuran Ghosh; Priyadarshan Kathirvel; Apurva Thilak; Yash T Katakia; Kavitha Sankaranarayanan; Suvro Chatterjee
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-07-07       Impact factor: 3.000

Review 7.  Pathological Roles of Iron in Cardiovascular Disease.

Authors:  Motoi Kobayashi; Tomohiro Suhara; Yuichi Baba; Nicholas K Kawasaki; Jason K Higa; Takashi Matsui
Journal:  Curr Drug Targets       Date:  2018       Impact factor: 3.465

8.  Vascular smooth muscle Jak2 deletion prevents angiotensin II-mediated neointima formation following injury in mice.

Authors:  Annet Kirabo; S Paul Oh; Hideko Kasahara; Kay-Uwe Wagner; Peter P Sayeski
Journal:  J Mol Cell Cardiol       Date:  2011-03-17       Impact factor: 5.000

9.  Treatment with quercetin and 3',4'-dihydroxyflavonol inhibits platelet function and reduces thrombus formation in vivo.

Authors:  S Mosawy; D E Jackson; O L Woodman; M D Linden
Journal:  J Thromb Thrombolysis       Date:  2013-07       Impact factor: 2.300

10.  Red blood cells mediate the onset of thrombosis in the ferric chloride murine model.

Authors:  Justin D Barr; Anil K Chauhan; Gilbert V Schaeffer; Jessica K Hansen; David G Motto
Journal:  Blood       Date:  2013-01-23       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.